Clinical trials: Colitis, Microscopic
Collagenous Colitis
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.
- Trial name
- NCT00450086
- Testing
- Budesonide, Mesalazine
- Where
- Germany
- Volunteers
- 92 people
- Sponsor
- Dr. Falk Pharma GmbH
Induction and Maintaining Remission of Collagenous Colitis
SOIBD Collagenous Colitis Maintenance Study
This study aims to demonstrate the superiority of budesonide compared to placebo as maintenance therapy in keeping patients in remission over a one-year period
- Trial name
- SCCMS (NCT01278082)
- Testing
- Budesonide
- Where
- 2 sites in Germany, Sweden
- Volunteers
- 92 people
- Sponsor
- Dr. Falk Pharma GmbH
Incomplete Microscopic Colitis
Budesonide for Induction of Remission in Incomplete Microscopic Colitis
The purpose of this study is to demonstrate the efficacy of budesonide for the treatment of active incomplete microscopic colitis.
- Trial name
- NCT02142634
- Testing
- Budesonide granules 9 mg
- Where
- 2 sites in Germany, Sweden
- Volunteers
- 44 people
- Sponsor
- Dr. Falk Pharma GmbH
Microscopic Colitis
A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Remission
This is a parallel, placebo-controlled, multicenter, randomized, double-blind, Phase 2, proof of concept study. The study aims to evaluate the efficacy and safety of SAR444336 in adult participants with microscopic colitis.
- Trial name
- NCT07156175
- Testing
- SAR444336
- Where
- 24 sites in Belgium, Denmark and 7 more
- Volunteers
- 54 people
- Sponsor
- Sanofi
Lymphocytic Colitis
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of lymphocytic colitis.
- Trial name
- NCT01209208
- Testing
- Budesonide, Mesalamine
- Where
- Germany
- Volunteers
- 57 people
- Sponsor
- Dr. Falk Pharma GmbH
Ulcerative Colitis, Crohn Disease
Systems Biology of Gastrointestinal and Related Diseases
This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and…
- Conditions
- Ulcerative Colitis, Crohn Disease, Obesity, Colon Polyp
- Trial name
- NCT05579444
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Viome